Werfen UK are pleased to announce that they will exhibiting at the the UK Stroke Forum a coalition of over 30 organisations all committed to improving stroke care in the UK. The coalition is underwritten by the Stroke Association and the British Association of Stroke Physicians. This year’s forum event will see:
- Over 20 main conference sessions, each focused on a different aspect of stroke care.
- Over 110 expert speakers and researchers giving talks on the latest research updates and service improvements.
- Over 60 exhibition stands to showcase new innovations and industry developments.
- Over 300 research posters including ongoing trials.
Understanding a patient’s unique response to antiplatelet medications is essential to effective treatment decisions. The VerifyNow IVD device manufactured by Werfen offers platelet reactivity results in minutes, providing antiplatelet therapy guidance in many clinical settings.
The VerifyNow System provides an easy, rapid, and proven solution to assess platelet reactivity to antiplatelet medications, such as Aspirin and clopidogrel.
Testing can measure the effect of antiplatelet therapy prior to discharge, ensure patient drug response to generic medications, identify patients at risk for an antiplatelet-related bleeding or major adverse cardiac event and identify therapeutic non-compliance.
This is the perfect opportunity to learn more about our IVD solution the VerifyNow in the management of Anti Platelet drugs. Werfen look forward to welcoming all those in attendance.